The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand
Tóm tắt
Concerns about the long-term sustainability of health care expenditures (HCEs), particularly prescribing expenditures, has become an important policy issue in most developed countries. Previous studies suggest that proximity to death (PTD) has a significant effect on total HCEs, with its exclusion leading to an overestimation of likely growth. There are limited studies of pharmaceutical expenditures in which PTD is taken into account. This study presents an empirical analysis of public medication expenditure on older individuals in New Zealand (NZ). The aim of the study was to examine the individual effects of age and PTD using individual-level data. This study uses individual-level dispensing data from 2008/2009 covering the whole population of medication users aged 70 years or older and resident in NZ. A case–control methodology was used to examine individual cost and medication use for a 12-month period for decedents (cases) and survivors (controls). A random effects two-part model, with a Probit and generalized linear model (GLM) was used to explore the effect of age and PTD on expenditures. The impact of PTD on prescription expenditure is not as dramatic as studies reporting on acute and/or long-term care. The 12-month decedent-to-survivor mean expenditure ratio was 1.95; 2.09 for males and 1.82 for females. The additional cost of dying in terms of prescription drugs decreases with age, with those who die at 90 years of age or older consuming fewer drugs on average and having a lower mean expenditure than those who died in their 70s and 80s. The following variables were found to have a decreasing effect on the mean monthly prescription expenditures: a reduction of 2.2 % for each additional year of age, 4.2 % being in the Maori ethnic group, and 7.8 % for Pacific Islanders. Increases in monthly expenditure were associated with being a decedent 32.1–62.6 % (depending on month), being of Asian origin 16.2 %, or being a male 12.6 %. Given the variance reported between survivors and decedents, future projections should include PTD in their models to improve accuracy. Policies targeted at reducing expenditures should not focus on age but on ensuring appropriate and cost-effective prescribing, particularly towards the end of life.
Tài liệu tham khảo
Statistics New Zealand. National population projections: 2009 (base)–2061. Wellington: Statistics New Zealand. 2009. Available from: http://www.stats.govt.nz/browse_for_stats/population/estimates_and_projections/NationalPopulationProjections_HOTP09base-61.aspx. Accessed 27 Oct 2012.
Labour force statistics: population projections, OECD employment and labour market statistics (database). 2011. Available from: http://www.oecd-ilibrary.org/employment/data/labour-force-statistics/historical-population-data-and-projections_data-00538-en;jsessionid=ba3jrdodrsu7f.delta?isPartOf=/content/datacollection/lfs-lfs-data-en. Accessed 21 May 2013.
World population prospects: the 2012 revision. United Nations. 2013. Available from: http://esa.un.org/unpd/wpp/index.htm. Accessed 1 Oct 2013.
Miller T. Increasing longevity and medicare expenditures. Demography. 2001;38(2):215–26.
Dormont B, Grignon M, Huber H. Health expenditure growth: reassessing the threat of ageing. Health Econ. 2006;15(9):947–63.
Fuchs VR. “Though much is taken”: reflections on ageing, health and medical care. Milbank Mem Fund Q Health Soc. 1984;61(1):143–66.
Scitovsky AA. “The high cost of dying” revisited. Milbank Q. 1994;72(4):561–91.
Comas-Herrera A, Wittenberg R, Pickard L, Knapp M. Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry. 2007;22:1037–45.
Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of ‘red herrings’? Health Econ. 2007;16(10):1109–26.
Zweifel P, Felder S, Meiers M. Ageing of population and health care expenditure: a red herring? Health Econ. 1999;8(6):485–96.
Seshamani M, Gray AM. A longitudinal study of the effects of age and time to death on hospital costs. J Health Econ. 2004;23(2):217–35.
Colombier C, Weber W. Projecting health-care expenditure for Switzerland: further evidence against the ‘red-herring’ hypothesis. Int J Health Plan Manage. 2011;26(3):246–63. doi:10.1002/hpm.1068.
de Meijer C, Koopmanschap M, d’ Uva TB, van Doorslaer E. Determinants of long-term care spending: age, time to death or disability? J Health Econ. 2011;30(2):425–38.
van Baal PH, Wong A. Time to death and the forecasting of macro-level health care expenditures: some further considerations. J Health Econ. 2012;31(6):876–87.
Healthdata. Organisation for Economic Co-operation and Development. 2013. Accessed 30 Sep 2013.
Seshamani M, Gray AM. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs. Age Ageing. 2004;33(6):556–61.
Kildemoes H, Christiansen T, Gyrd-Hansen D. The impact of population ageing on future Danish drug expenditure. Health Policy. 2006;75:298–311.
OECD. Health at a glance 2011: OECD indicators. 2011. Available from: http://www.oecd.org/els/health-systems/health-at-a-glance.htm.
Iacus SM, King G, Porro G. Multivariate matching methods that are monotonic imbalance bounding. J Am Stat Assoc. 2011;106(493):345–61.
Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18(2):153–71.
Manning W, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.
Duan N. Smearing estimate: a non-parametric retransformation method. J Am Stat Assoc. 1983;78:605–10.
Barber J, Thompson S. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. BMJ. 1998;317:1195–200.
Barber J, Thompson S. Analysis of cost data in randomised controlled trials: an application of the non-parametric bootstrap. Med Stat. 2000;19(23):3219–36.
Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models of the demand for medical care. J Bus Econ Stat. 1983;1(2):115–26.
Jones AM. Health econometrics. In: Culyer A, Newhouse J, editors. Handbook of health economics. Amsterdam: Elsevier; 2000.
Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, editors. Second international symposium on information theory. Budapest: Akademiai Kiado; 1973: pp. 267–281.
Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy. 2004;9(4):197–204. doi:10.1258/1355819042250249.
Bjørner TB, Arnberg S. Terminal costs, improved life expectancy and future public health expenditure. Int J Health Care Finance Econ. 2012;12:129–43.
Aspin C, Jowsey T, Glasgow N, Dugdale P, Nolte E, O’Hallahan J, et al. Health policy responses to rising rates of multi-morbid chronic illness in Australia and New Zealand. Aust NZ J Public Health. 2010;34(4):386–93.
McGrail K, Green B, Barer ML, Evans RG, Hertzman C, Normand C. Age, costs of acute and long-term care and proximity to death: evidence for 1987–88 and 1994–95 in British Columbia. Age Ageing. 2000;29(3):249–53.
Lubitz J, Beebe J, Baker C. Longevity and medicare expenditures. N Engl J Med. 1995;332(15):999–1002.
Angulo AM, Barberán R, Egea P, Mur J. An analysis of health expenditure on a microdata population basis. Econ Model. 2011;28:169–80.
Yang Z, Norton EC, Stearns SC. Longevity and health care expenditures: the real reasons older people spend more. J Gerontol B Psychol Sci Soc Sci. 2003;58(1):S2–10.
Felder S, Werblow A, Zweifel P. Do red herrings swim in circles? Controlling for the endogeneity of time to death. J Health Econ. 2010;29(2):205–12.
Blakely T, Fawcett J, Atkinson J, Tobias M, Cheung J. Decades of disparity II: socioeconomic mortality trends in New Zealand, 1981–1999. Wellington: Ministry of Health; 2005.
Ministry of health. Tatau Kura Tangata: Health of Older Maori Chart Book 2011 Wellington: Ministry of Health (NZ); 2011.
McNaughton H, Weatherall M, McPherson K, Taylor W, Harwood M. The comparability of resource utilisation for Europeans and non-Europeans following stroke in New Zealand. NZ Med J. 2002;115(1149):101–3.
Scott K, Marwick J, Crampton P. Utilization of general practitioner services in New Zealand and its relationship with income, ethnicity and government subsidy. Health Serv Manage Res. 2003;16(1):45–55.
Crimmins EM, Saito Y, Ingegnenri D. Trends in disability-free life expectancy in the United States. Popul Dev Rev. 1997;23:555–72.
Waidmann TA, Liu K. Disability trends among elderly persons and implications for the future. J Gerontol. 2000;55:S298–307.
Statistics New Zealand. New Zealand period life tables: 2010–12. Wellington: Statistics New Zealand; 2013. Available from: http://www.stats.govt.nz/browse_for_stats/health/life_expectancy/NZLifeTables_HOTP10-12.aspx. Accessed 20 Apr 2013.
Gandjour A, Lauterbach KW. Does prevention save costs? Considering deferral of the expensive last year of life. J Health Econ. 2005;24(4):715–24.
Gandjour A. Aging diseases: do they prevent preventive health care from saving costs? Health Econ. 2009;18(3):355–62.
Broad JB, Ashton T, Lumley T, Connolly MJ. Reports of the proportion of older people living in long-term care: a cautionary tale from New Zealand. Aust NZ J Public Health. 2013;27(3):264–71.
Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med. 2000;342(19):1409–15.
Statistics New Zealand. National population estimates 2008. Wellington: Statistics New Zealand; 2011. Available from: http://www.stats.govt.nz/browse_for_stats/population/estimates_and_projections/national-pop-estimates.aspx. Accessed 21 Jun 2011.